<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on 24.10.2026 at 6:27 am by All in One SEO v5.0.4 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cq-platform.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Cq-Platform</title>
		<link><![CDATA[https://cq-platform.com]]></link>
		<description><![CDATA[Cq-Platform]]></description>
		<lastBuildDate><![CDATA[Sat, 24 Oct 2026 05:42:26 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cq-platform.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cq-platform.com/advanced-instant-medical-question-search/]]></guid>
			<link><![CDATA[https://cq-platform.com/advanced-instant-medical-question-search/]]></link>
			<title>Advanced Instant Medical Question search</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 05:42:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/become-an-instructor/]]></guid>
			<link><![CDATA[https://cq-platform.com/become-an-instructor/]]></link>
			<title>Join Our Instructors Team</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 05:41:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/online-emle-egyptian-medical-license-examination/]]></guid>
			<link><![CDATA[https://cq-platform.com/online-emle-egyptian-medical-license-examination/]]></link>
			<title>Online EMLE &#8211; Egyptian Medical License Examination</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 05:26:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/login-2/]]></guid>
			<link><![CDATA[https://cq-platform.com/login-2/]]></link>
			<title>Log In</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 05:25:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/term_conditions/]]></guid>
			<link><![CDATA[https://cq-platform.com/term_conditions/]]></link>
			<title>Terms and Conditions</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 04:44:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/courses/cardiology/]]></guid>
			<link><![CDATA[https://cq-platform.com/courses/cardiology/]]></link>
			<title>Cardiology</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 04:41:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/instructor/]]></guid>
			<link><![CDATA[https://cq-platform.com/instructor/]]></link>
			<title>Instructor</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 04:37:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/instructors/]]></guid>
			<link><![CDATA[https://cq-platform.com/instructors/]]></link>
			<title>Instructors</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 04:36:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/best-performance-board/]]></guid>
			<link><![CDATA[https://cq-platform.com/best-performance-board/]]></link>
			<title>Best performance board</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:54:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/member-results-statistics/]]></guid>
			<link><![CDATA[https://cq-platform.com/member-results-statistics/]]></link>
			<title>Member results &amp; statistics</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:53:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/membership-account/membership-cancel/]]></guid>
			<link><![CDATA[https://cq-platform.com/membership-account/membership-cancel/]]></link>
			<title>Membership Cancellation</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:52:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/membership-levels/]]></guid>
			<link><![CDATA[https://cq-platform.com/membership-levels/]]></link>
			<title>Membership Levels</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:51:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/membership-account/your-profile/]]></guid>
			<link><![CDATA[https://cq-platform.com/membership-account/your-profile/]]></link>
			<title>Your Profile</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:50:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/membership-account/membership-orders/]]></guid>
			<link><![CDATA[https://cq-platform.com/membership-account/membership-orders/]]></link>
			<title>Membership Orders</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:49:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/membership-checkout/membership-confirmation/]]></guid>
			<link><![CDATA[https://cq-platform.com/membership-checkout/membership-confirmation/]]></link>
			<title>Membership Confirmation</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:48:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/checkout/]]></guid>
			<link><![CDATA[https://cq-platform.com/checkout/]]></link>
			<title>Checkout</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:47:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/membership-account/]]></guid>
			<link><![CDATA[https://cq-platform.com/membership-account/]]></link>
			<title>Membership Account</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:46:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/my-profile/]]></guid>
			<link><![CDATA[https://cq-platform.com/my-profile/]]></link>
			<title>My Profile</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:45:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/membership-plans/]]></guid>
			<link><![CDATA[https://cq-platform.com/membership-plans/]]></link>
			<title>Membership plans</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:40:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/]]></guid>
			<link><![CDATA[https://cq-platform.com/]]></link>
			<title>Gateway</title>
			<pubDate><![CDATA[Sat, 24 Oct 2026 02:34:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/courses/5-endocrinology/]]></guid>
			<link><![CDATA[https://cq-platform.com/courses/5-endocrinology/]]></link>
			<title>Endocrinology</title>
			<pubDate><![CDATA[Sun, 04 Oct 2026 22:23:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/lessons/diabetic-ketoacidosis-dka/]]></guid>
			<link><![CDATA[https://cq-platform.com/lessons/diabetic-ketoacidosis-dka/]]></link>
			<title>Diabetic ketoacidosis (DKA)</title>
			<pubDate><![CDATA[Sun, 04 Oct 2026 22:23:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/quizzes/diagnostic-approach-and-correction-strategies/]]></guid>
			<link><![CDATA[https://cq-platform.com/quizzes/diagnostic-approach-and-correction-strategies/]]></link>
			<title>Diagnostic approach and correction strategies</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 15:02:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-patient-is-evaluated-for-suspected-rhabdomyolysis-after-being-found-immobile-on-the-floor-for-several-hours-which-of-the-following-urinalysis-profiles-is-pathognomonic-for-this-condition/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-patient-is-evaluated-for-suspected-rhabdomyolysis-after-being-found-immobile-on-the-floor-for-several-hours-which-of-the-following-urinalysis-profiles-is-pathognomonic-for-this-condition/]]></link>
			<title>A patient is evaluated for suspected rhabdomyolysis after being found immobile on the floor for several hours. Which of the following urinalysis profiles is pathognomonic for this condition?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 15:00:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/in-evaluating-the-adequacy-of-hemodialysis-kt-v-is-clinically-recognized-as-more-accurate-and-comprehensive-than-the-urea-reduction-ratio-urr-what-does-the-kt-v-calculation-specifically-account-fo/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/in-evaluating-the-adequacy-of-hemodialysis-kt-v-is-clinically-recognized-as-more-accurate-and-comprehensive-than-the-urea-reduction-ratio-urr-what-does-the-kt-v-calculation-specifically-account-fo/]]></link>
			<title>In evaluating the adequacy of hemodialysis, Kt/V is clinically recognized as more accurate and comprehensive than the Urea Reduction Ratio (URR). What does the Kt/V calculation specifically account for that the URR excludes?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:58:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/which-of-the-following-clinical-scenarios-represents-an-absolute-urgent-indication-for-initiating-hemodialysis-based-on-the-aeiou-mnemonic/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/which-of-the-following-clinical-scenarios-represents-an-absolute-urgent-indication-for-initiating-hemodialysis-based-on-the-aeiou-mnemonic/]]></link>
			<title>Which of the following clinical scenarios represents an absolute, urgent indication for initiating hemodialysis based on the &#8220;AEIOU&#8221; mnemonic?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:56:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-patient-on-chronic-loop-diuretic-therapy-presents-with-persistent-hypokalemia-and-hypocalcemia-that-fail-to-normalize-despite-aggressive-oral-and-intravenous-potassium-and-calcium-supplementation-w/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-patient-on-chronic-loop-diuretic-therapy-presents-with-persistent-hypokalemia-and-hypocalcemia-that-fail-to-normalize-despite-aggressive-oral-and-intravenous-potassium-and-calcium-supplementation-w/]]></link>
			<title>A patient on chronic loop diuretic therapy presents with persistent hypokalemia and hypocalcemia that fail to normalize despite aggressive oral and intravenous potassium and calcium supplementation. What is the most appropriate next step?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:55:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-euvolemic-patient-has-a-serum-sodium-of-124-meq-l-serum-osmolarity-of-260-mosm-kg-and-a-urine-sodium-of-45-meq-l-with-a-urine-osmolarity-of-450-mosm-kg-thyroid-and-adrenal-functions-are-normal-w/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-euvolemic-patient-has-a-serum-sodium-of-124-meq-l-serum-osmolarity-of-260-mosm-kg-and-a-urine-sodium-of-45-meq-l-with-a-urine-osmolarity-of-450-mosm-kg-thyroid-and-adrenal-functions-are-normal-w/]]></link>
			<title>A euvolemic patient has a serum sodium of 124 mEq/L, serum osmolarity of 260 mOsm/kg, and a urine sodium of 45 mEq/L with a urine osmolarity of 450 mOsm/kg. Thyroid and adrenal functions are normal. What is the diagnosis and primary treatment approach?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:52:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-72-year-old-patient-with-stage-3b-ckd-and-diabetes-requires-a-contrast-enhanced-ct-scan-what-is-the-gold-standard-diagnostic-and-preventative-protocol-to-minimize-the-risk-of-contrast-induced-acute/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-72-year-old-patient-with-stage-3b-ckd-and-diabetes-requires-a-contrast-enhanced-ct-scan-what-is-the-gold-standard-diagnostic-and-preventative-protocol-to-minimize-the-risk-of-contrast-induced-acute/]]></link>
			<title>A 72-year-old patient with Stage 3b CKD and Diabetes requires a contrast-enhanced CT scan. What is the gold-standard diagnostic and preventative protocol to minimize the risk of contrast-induced acute kidney injury?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:52:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/in-a-patient-with-severe-diabetic-ketoacidosis-dka-presenting-with-a-blood-ph-of-7-15-and-a-serum-potassium-of-3-6-meq-l-what-must-the-physician-prioritize-during-insulin-and-fluid-correction/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/in-a-patient-with-severe-diabetic-ketoacidosis-dka-presenting-with-a-blood-ph-of-7-15-and-a-serum-potassium-of-3-6-meq-l-what-must-the-physician-prioritize-during-insulin-and-fluid-correction/]]></link>
			<title>In a patient with severe diabetic ketoacidosis (DKA) presenting with a blood pH of 7.15 and a serum potassium of 3.6 mEq/L, what must the physician prioritize during insulin and fluid correction?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:51:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-young-adult-is-evaluated-for-hypokalemic-metabolic-alkalosis-and-normal-blood-pressure-to-differentiate-gitelman-syndrome-from-bartter-syndrome-the-clinician-measures-24-hour-urinary-calcium-excre/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-young-adult-is-evaluated-for-hypokalemic-metabolic-alkalosis-and-normal-blood-pressure-to-differentiate-gitelman-syndrome-from-bartter-syndrome-the-clinician-measures-24-hour-urinary-calcium-excre/]]></link>
			<title>A young adult is evaluated for hypokalemic metabolic alkalosis and normal blood pressure. To differentiate Gitelman syndrome from Bartter syndrome, the clinician measures 24-hour urinary calcium excretion. What is the expected diagnostic finding?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:50:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-patient-presents-with-severe-hypokalemia-2-2-meq-l-accompanied-by-prominent-u-waves-on-ecg-and-mild-metabolic-acidosis-which-of-the-following-describes-the-safest-and-most-appropriate-pharmacolog/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-patient-presents-with-severe-hypokalemia-2-2-meq-l-accompanied-by-prominent-u-waves-on-ecg-and-mild-metabolic-acidosis-which-of-the-following-describes-the-safest-and-most-appropriate-pharmacolog/]]></link>
			<title>A patient presents with severe hypokalemia (2.2 mEq/L) accompanied by prominent U waves on ECG and mild metabolic acidosis. Which of the following describes the safest and most appropriate pharmacologic correction strategy?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:48:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-patient-with-long-standing-diabetes-presents-with-normal-anion-gap-metabolic-acidosis-and-a-serum-potassium-of-5-8-meq-l-which-is-disproportionate-to-their-moderate-renal-impairment-egfr-of-45-ml/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-patient-with-long-standing-diabetes-presents-with-normal-anion-gap-metabolic-acidosis-and-a-serum-potassium-of-5-8-meq-l-which-is-disproportionate-to-their-moderate-renal-impairment-egfr-of-45-ml/]]></link>
			<title>A patient with long-standing diabetes presents with normal anion gap metabolic acidosis and a serum potassium of 5.8 mEq/L, which is disproportionate to their moderate renal impairment (eGFR of 45 mL/min). What is the most appropriate long-term management strategy for this condition?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:47:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/to-differentiate-between-type-1-distal-and-type-2-proximal-renal-tubular-acidosis-rta-which-of-the-following-diagnostic-responses-is-correct/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/to-differentiate-between-type-1-distal-and-type-2-proximal-renal-tubular-acidosis-rta-which-of-the-following-diagnostic-responses-is-correct/]]></link>
			<title>To differentiate between Type 1 (distal) and Type 2 (proximal) Renal Tubular Acidosis (RTA), which of the following diagnostic responses is correct?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:45:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/in-a-patient-with-stable-stage-4-chronic-kidney-disease-ckd-who-has-chronic-mild-metabolic-acidosis-what-is-the-primary-therapeutic-target-and-standard-of-care-to-slow-renal-and-bone-disease-progr/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/in-a-patient-with-stable-stage-4-chronic-kidney-disease-ckd-who-has-chronic-mild-metabolic-acidosis-what-is-the-primary-therapeutic-target-and-standard-of-care-to-slow-renal-and-bone-disease-progr/]]></link>
			<title>In a patient with stable Stage 4 Chronic Kidney Disease (CKD) who has chronic, mild metabolic acidosis, what is the primary therapeutic target and standard of care to slow renal and bone disease progression?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:44:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-patient-with-multiple-myeloma-is-found-to-have-a-serum-sodium-of-122-meq-l-on-a-routine-metabolic-panel-but-the-measured-serum-osmolarity-is-completely-normal-at-285-mosm-kg-what-is-the-correct-cl/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-patient-with-multiple-myeloma-is-found-to-have-a-serum-sodium-of-122-meq-l-on-a-routine-metabolic-panel-but-the-measured-serum-osmolarity-is-completely-normal-at-285-mosm-kg-what-is-the-correct-cl/]]></link>
			<title>A patient with Multiple Myeloma is found to have a serum sodium of 122 mEq/L on a routine metabolic panel, but the measured serum osmolarity is completely normal at 285 mOsm/kg. What is the correct clinical interpretation and subsequent step?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:43:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-patient-presents-with-high-anion-gap-metabolic-acidosis-the-calculated-osmolarity-using-the-formula-2-x-na-glucose-18-urea-6-is-290-mosm-l-whereas-the-measured-osmolarity-on-a-freezing-point/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-patient-presents-with-high-anion-gap-metabolic-acidosis-the-calculated-osmolarity-using-the-formula-2-x-na-glucose-18-urea-6-is-290-mosm-l-whereas-the-measured-osmolarity-on-a-freezing-point/]]></link>
			<title>A patient presents with high anion gap metabolic acidosis. The calculated osmolarity using the formula 2 x Na+ + Glucose/18 + Urea/6 is 290 mOsm/L, whereas the measured osmolarity on a freezing-point osmometer is 315 mOsm/L. This osmolar gap of 25 mOsm/L suggests which of the following?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:42:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/in-the-differential-diagnosis-of-acute-kidney-injury-aki-which-of-the-following-laboratory-profiles-most-reliably-distinguishes-a-functional-prerenal-state-from-established-acute-tubular-necros/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/in-the-differential-diagnosis-of-acute-kidney-injury-aki-which-of-the-following-laboratory-profiles-most-reliably-distinguishes-a-functional-prerenal-state-from-established-acute-tubular-necros/]]></link>
			<title>In the differential diagnosis of acute kidney injury (AKI), which of the following laboratory profiles most reliably distinguishes a functional &#8220;prerenal&#8221; state from established acute tubular necrosis (ATN)?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:40:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-55-year-old-patient-with-an-egfr-of-14-ml-min-presents-with-a-serum-potassium-of-7-2-meq-l-the-electrocardiogram-ecg-reveals-tall-tented-t-waves-and-a-widened-qrs-complex-which-of-the-following/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-55-year-old-patient-with-an-egfr-of-14-ml-min-presents-with-a-serum-potassium-of-7-2-meq-l-the-electrocardiogram-ecg-reveals-tall-tented-t-waves-and-a-widened-qrs-complex-which-of-the-following/]]></link>
			<title>A 55-year-old patient with an eGFR of 14 mL/min presents with a serum potassium of 7.2 mEq/L. The electrocardiogram (ECG) reveals tall, tented T waves and a widened QRS complex. Which of the following is the most immediate first-line medication that must be administered?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:39:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/which-of-the-following-mixed-acid-base-disorders-is-classically-caused-by-acute-salicylate-aspirin-toxicity-due-to-its-concurrent-effects-on-the-central-nervous-system-and-mitochondrial-metabolism/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/which-of-the-following-mixed-acid-base-disorders-is-classically-caused-by-acute-salicylate-aspirin-toxicity-due-to-its-concurrent-effects-on-the-central-nervous-system-and-mitochondrial-metabolism/]]></link>
			<title>Which of the following mixed acid-base disorders is classically caused by acute salicylate (aspirin) toxicity due to its concurrent effects on the central nervous system and mitochondrial metabolism?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:38:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-patient-with-severe-diarrhea-is-admitted-with-metabolic-acidosis-and-a-serum-bicarbonate-hco3-of-12-meq-l-utilizing-winters-formula-what-is-the-expected-compensatory-arterial-pco2-range-if-th/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-patient-with-severe-diarrhea-is-admitted-with-metabolic-acidosis-and-a-serum-bicarbonate-hco3-of-12-meq-l-utilizing-winters-formula-what-is-the-expected-compensatory-arterial-pco2-range-if-th/]]></link>
			<title>A patient with severe diarrhea is admitted with metabolic acidosis and a serum bicarbonate (HCO3-) of 12 mEq/L. Utilizing Winter&#8217;s formula, what is the expected compensatory arterial PCO2 range if there is a normal respiratory compensation?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:34:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/when-managing-chronic-asymptomatic-hyponatremia-what-is-the-recommended-maximum-safe-rate-of-serum-sodium-correction-over-a-24-hour-period-to-avoid-the-catastrophic-development-of-osmotic-demyelinat/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/when-managing-chronic-asymptomatic-hyponatremia-what-is-the-recommended-maximum-safe-rate-of-serum-sodium-correction-over-a-24-hour-period-to-avoid-the-catastrophic-development-of-osmotic-demyelinat/]]></link>
			<title>When managing chronic, asymptomatic hyponatremia, what is the recommended maximum safe rate of serum sodium correction over a 24-hour period to avoid the catastrophic development of osmotic demyelination syndrome (central pontine myelinolysis)?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:33:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/a-clinician-is-correcting-severe-symptomatic-hyponatremia-in-a-60-kg-female-with-a-measured-serum-sodium-of-115-meq-l-to-safely-plan-the-initial-phase-of-sodium-replenishment-to-a-target-of-125-meq/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/a-clinician-is-correcting-severe-symptomatic-hyponatremia-in-a-60-kg-female-with-a-measured-serum-sodium-of-115-meq-l-to-safely-plan-the-initial-phase-of-sodium-replenishment-to-a-target-of-125-meq/]]></link>
			<title>A clinician is correcting severe, symptomatic hyponatremia in a 60 kg female with a measured serum sodium of 115 mEq/L. To safely plan the initial phase of sodium replenishment to a target of 125 mEq/L, what is the calculated total sodium deficit?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:32:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/an-elderly-70-kg-male-with-advanced-dementia-is-admitted-with-severe-dehydration-and-hypernatremia-his-serum-sodium-is-measured-at-160-meq-l-using-the-standard-formula-for-total-body-water-tbw-in/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/an-elderly-70-kg-male-with-advanced-dementia-is-admitted-with-severe-dehydration-and-hypernatremia-his-serum-sodium-is-measured-at-160-meq-l-using-the-standard-formula-for-total-body-water-tbw-in/]]></link>
			<title>An elderly 70 kg male with advanced dementia is admitted with severe dehydration and hypernatremia. His serum sodium is measured at 160 mEq/L. Using the standard formula for total body water (TBW) in males, what is this patient&#8217;s calculated free water deficit?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:31:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/quizzes/metabolic-acidosis-alkalosis-respiratory-acid-base-disorders/]]></guid>
			<link><![CDATA[https://cq-platform.com/quizzes/metabolic-acidosis-alkalosis-respiratory-acid-base-disorders/]]></link>
			<title>Metabolic acidosis &amp; alkalosis, respiratory acid-base disorders</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:22:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/in-the-diagnostic-evaluation-of-proximal-renal-tubular-acidosis-rta-type-2-which-of-the-following-is-the-standard-test-of-choice-to-confirm-the-proximal-tubule-bicarbonate-leak/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/in-the-diagnostic-evaluation-of-proximal-renal-tubular-acidosis-rta-type-2-which-of-the-following-is-the-standard-test-of-choice-to-confirm-the-proximal-tubule-bicarbonate-leak/]]></link>
			<title>In the diagnostic evaluation of proximal Renal Tubular Acidosis (RTA Type 2), which of the following is the standard test of choice to confirm the proximal tubule bicarbonate leak?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:21:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/distal-renal-tubular-acidosis-rta-type-1-is-a-tubulopathy-characterized-by-an-inability-to-acidify-urine-what-is-its-specific-molecular-defect-and-its-effect-on-urinary-ph/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/distal-renal-tubular-acidosis-rta-type-1-is-a-tubulopathy-characterized-by-an-inability-to-acidify-urine-what-is-its-specific-molecular-defect-and-its-effect-on-urinary-ph/]]></link>
			<title>Distal Renal Tubular Acidosis (RTA Type 1) is a tubulopathy characterized by an inability to acidify urine. What is its specific molecular defect and its effect on urinary pH?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:19:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/when-an-acid-base-disorder-develops-the-respiratory-system-acts-as-a-rapid-buffer-within-what-timeframe-does-the-pulmonary-adaptation-response-start-and-reach-its-peak/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/when-an-acid-base-disorder-develops-the-respiratory-system-acts-as-a-rapid-buffer-within-what-timeframe-does-the-pulmonary-adaptation-response-start-and-reach-its-peak/]]></link>
			<title>When an acid-base disorder develops, the respiratory system acts as a rapid buffer. Within what timeframe does the pulmonary adaptation response start and reach its peak?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:18:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/questions/salicylate-aspirin-toxicity-is-known-to-cause-a-complex-mixed-acid-base-disorder-which-of-the-following-describes-this-clinical-presentation/]]></guid>
			<link><![CDATA[https://cq-platform.com/questions/salicylate-aspirin-toxicity-is-known-to-cause-a-complex-mixed-acid-base-disorder-which-of-the-following-describes-this-clinical-presentation/]]></link>
			<title>Salicylate (aspirin) toxicity is known to cause a complex, mixed acid-base disorder. Which of the following describes this clinical presentation?</title>
			<pubDate><![CDATA[Sun, 06 Sep 2026 14:17:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cq-platform.com/blog/]]></guid>
			<link><![CDATA[https://cq-platform.com/blog/]]></link>
			<title>Blog</title>
			<pubDate><![CDATA[Sun, 11 May 2025 16:42:55 +0000]]></pubDate>
		</item>
				</channel>
</rss>
